-
Insurance Gaps Threaten Cancer Treatment Success
07 Jul 2025 22:10 GMT
… cell lung cancer (NSCLC), or renal cell carcinoma (RCC)—immune checkpoint inhibitors (ICIs) may … of insurance coverage changes on treatment access.
There are several limitations … approves Yervoy (ipilimumab) for the treatment of patients with newly diagnosed …
-
Novel Insights Into Chromophobe Renal Cell Carcinoma Biology and Potential Therapeutic Strategies
04 Jul 2025 05:13 GMT
… for new targets and treatments.
Those are among the … renal oncocytoma (RO).
“Chromophobe renal cell carcinoma remains a major challenge to … Most of the available treatments were developed for other … understanding of ChRCC and treatment pathways that could be …
-
Breakthrough Discoveries in Chromophobe Renal Cell Carcinoma Biology Open Doors to New Therapeutic Approaches
03 Jul 2025 20:25 GMT
… :50px !important;}
} ADVERTISEMENT “Chromophobe renal cell carcinoma remains a formidable clinical challenge … machine learning Tags: cancer treatment innovationschromophobe renal cell carcinoma researchimmune checkpoint inhibitors effectivenessimmune system …
-
Artificial Intelligence-Driven Innovations in Oncology Drug Discovery: Transforming Traditional Pipelines and Enhancing Drug Design
03 Jul 2025 15:28 GMT
… and safer medications as well as accelerating the drug discovery … and development of drugs for treatment oncology as shown … the treatment of non-small cell lung cancer, renal cell carcinoma, and … natural product‐based combination drugs. Med Res Rev. 2018;38 …
-
Survival Disparities Increase for Patients Without Health Insurance Following FDA Approval of Immune Checkpoint Inhibitors for Advanced Cancers, New ACS Study Shows
07 Jul 2025 21:44 GMT
… the highest-cost cancer drugs. The study is published … IV melanoma, NSCLC, or renal cell carcinoma using the National Cancer … people diagnosed with NSCLC and renal cell carcinoma. Of note, the … options and making new treatments more affordable are needed. …
-
Challenges in Diagnosis and Management of Acute Limb Ischemia 30 Days Postpartum in Lithotomy Position: A Case Report from Somalia Leading to Bilateral Lower Limb Amputation
07 Jul 2025 11:54 GMT
… rapid progression despite immediate medical treatment. This situation highlights the … HH. Spontaneous rupture of renal cell carcinoma: a case report from Mogadishu … period. N Engl J Med. 2014;370(14):1307– … diagnosis and management. J Clin Med. 2019;8(8):1215. …
-
These 5 ASX 200 healthcare shares gained the most weight in FY25
07 Jul 2025 02:00 GMT
… secured approval for its flagship drug, remestemcel-L, or Ryoncil … Revascor). Revascor is a treatment for patients with ischemic heart … for the imaging and treatment of solid cancer tumours. … the imaging of clear cell renal cell carcinoma (ccRCC), may be …
-
Rare kidney cancer evades immune system in unique ways
06 Jul 2025 14:44 GMT
… for new targets and treatments.
Those are among the … Most of the available treatments were developed for other … understanding of ChRCC and treatment pathways that could be … Antitumor Immunity in Chromophobe Renal Cell Carcinoma. Journal of Clinical Oncology. …
-
Top 10 Urology Times videos from the first half of 2025
04 Jul 2025 15:41 GMT
… (I) in previously untreated advanced renal cell carcinoma (aRCC): Final results of COSMIC … intravesical therapy and surgery as treatment options (CISTO) study” Watch the … discussions regarding screening, diagnosis, and treatment of the disease. In a …
-
Unveiling Advances in GU Cancers: Insights from Oncology Decoded
03 Jul 2025 18:21 GMT
… trial for patients with renal cell carcinoma (RCC). This study investigated pembrolizumab … due to drug toxicity, which can make the treatment arm… the timeline for new drugs to be incorporated … pembrolizumab in renal-cell carcinoma. N Engl J Med. 2024;390 …
About
© 1995-2025